ICYMI: SRP-9003 Study Shows Positive Results for Treating LGMD Type 2E
27707 / Pixabay

ICYMI: SRP-9003 Study Shows Positive Results for Treating LGMD Type 2E

  In a recent press release, biotechnology company Sarepta Therapeutics announced positive findings from their clinical trial studying SRP-9003 as a treatment for limb-girdle muscular dystrophy (LGMD) type 2E. This…

Continue Reading ICYMI: SRP-9003 Study Shows Positive Results for Treating LGMD Type 2E
How Rogue Astrocytes Cause Neurodegeneration
GerryShaw / CC BY-SA (https://creativecommons.org/licenses/by-sa/3.0)

How Rogue Astrocytes Cause Neurodegeneration

  You have a number of different cells throughout your body, all of which perform different functions or provide support. One extremely interesting type are astrocytes, star-shaped glial cells that…

Continue Reading How Rogue Astrocytes Cause Neurodegeneration
CDC Hosts Webinar on the Struggles of Those with Chronic Diseases During COVID-19 crisis
source: pixabay.com

CDC Hosts Webinar on the Struggles of Those with Chronic Diseases During COVID-19 crisis

  During this time of COVID-19, many people have some general information about COvID-19 including the knowledge that individuals over 65 years of age are at higher risk of contracting…

Continue Reading CDC Hosts Webinar on the Struggles of Those with Chronic Diseases During COVID-19 crisis
AGA Recommendations: No Probiotics for Patients with Ulcerative Colitis and Other Digestive Disorders
Sourced from Daily Nouri on Unsplash

AGA Recommendations: No Probiotics for Patients with Ulcerative Colitis and Other Digestive Disorders

  Over the last few years, I've heard the refrain that my health - oddly - starts in my gut. So whenever I got sick, someone would advise me to…

Continue Reading AGA Recommendations: No Probiotics for Patients with Ulcerative Colitis and Other Digestive Disorders
Protego-PD, for Necrotizing Enterocolitis, Receives Orphan Drug and Rare Pediatric Disease Designations
Found on: Unsplash

Protego-PD, for Necrotizing Enterocolitis, Receives Orphan Drug and Rare Pediatric Disease Designations

  Plakous Therapeutics released a press release to announce that Protego-PD™, their therapy for infants with necrotizing enterocolitis (NEC), received both the Orphan Drug and Rare Pediatric Disease designations from the FDA. There are…

Continue Reading Protego-PD, for Necrotizing Enterocolitis, Receives Orphan Drug and Rare Pediatric Disease Designations
Close Menu